ONCAlert | 2017 San Antonio Breast Cancer Symposium

Deciding Between Hormone Therapies in Patients With ER+/PR+ Tumors

Ragene Rivera, MD
Published Online:10:15 AM, Tue August 12, 2014
Ragene Rivera, MD, medical oncologist, Texas Oncology-El Paso Cancer Treatment Center, discusses how she decides between hormone therapies in patients with ER+/PR+ tumors.

This segment is a part of our Case-Based Peer Perspectives. View the case details > >
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.